GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Flerie AB (STU:1NP1) » Definitions » EV-to-EBITDA

Flerie AB (STU:1NP1) EV-to-EBITDA : -19.62 (As of May. 31, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Flerie AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Flerie AB's enterprise value is €244.17 Mil. Flerie AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was €-12.45 Mil. Therefore, Flerie AB's EV-to-EBITDA for today is -19.62.

The historical rank and industry rank for Flerie AB's EV-to-EBITDA or its related term are showing as below:

STU:1NP1' s EV-to-EBITDA Range Over the Past 10 Years
Min: -26.39   Med: -4.18   Max: 12.46
Current: -19.45

During the past 11 years, the highest EV-to-EBITDA of Flerie AB was 12.46. The lowest was -26.39. And the median was -4.18.

STU:1NP1's EV-to-EBITDA is ranked worse than
100% of 497 companies
in the Biotechnology industry
Industry Median: 8.25 vs STU:1NP1: -19.45

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-31), Flerie AB's stock price is €3.845. Flerie AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.356. Therefore, Flerie AB's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Flerie AB EV-to-EBITDA Historical Data

The historical data trend for Flerie AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flerie AB EV-to-EBITDA Chart

Flerie AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.39 -4.92 -1.09 0.35 -12.40

Flerie AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 -4.78 -7.99 -12.40 -19.41

Competitive Comparison of Flerie AB's EV-to-EBITDA

For the Biotechnology subindustry, Flerie AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flerie AB's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Flerie AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Flerie AB's EV-to-EBITDA falls into.


;
;

Flerie AB EV-to-EBITDA Calculation

Flerie AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=244.172/-12.447
=-19.62

Flerie AB's current Enterprise Value is €244.17 Mil.
Flerie AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Flerie AB  (STU:1NP1) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Flerie AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.845/-0.356
=At Loss

Flerie AB's share price for today is €3.845.
Flerie AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.356.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Flerie AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Flerie AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Flerie AB Business Description

Traded in Other Exchanges
Address
Skeppsbron 16, Stockholm, SWE, 111 30
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.

Flerie AB Headlines

No Headlines